Don’t Forget About the Flu! Identifying, Treating, and Protecting High-Risk Patients



Release Date: November 19, 2021
Expiration Date: November 19, 2022
Time to Complete Activity: 1.0 hour

Faculty
Jason E. Bowling, MD, FIDSA

Associate Professor
Department of Medicine
Division of Infectious Diseases
UT Health San Antonio
San Antonio, TX 

James S. Lewis II, PharmD, FIDSA 
Infectious Diseases Pharmacy Supervisor
Co-Director of Antibiotic Stewardship
Departments of Pharmacy and Infectious Diseases
Oregon Health & Science University
Portland, OR

This activity is jointly provided by Educational Review Systems, Inc and Paradigm Medical Communications, LLC. 
                                                                                              


Disclosure of Financial Support
This activity is supported by an educational grant from Genentech, a member of the Roche Group.

Target Audience
This activity has been designed to address the educational needs of community, health-system, and hospital pharmacists. It may also benefit other clinicians involved in the care of patients with, or at risk for, influenza virus infection. 

Statement of Need 
Many US states have expanded the role of pharmacists in influenza, which remains a persistent threat. Pharmacists are essential to influenza prevention and preparedness efforts, and their involvement in influenza care is consistently shown to improve outcomes. This evidence-based program will provide pharmacists with updates on best practices for identifying influenza and guiding the use of antiviral therapy, which is currently underused, even among high-risk patients who are susceptible to worse outcomes. The program will acquaint pharmacists with shifts in influenza diagnosis and care that have been prompted by the emergence of COVID-19, and the availability of a first-in-class oral antiviral agent, for which data, indications, and formulations continue to accumulate, warranting immediate practice changes in both treatment and prophylaxis.

Learning Objectives
Upon completion of this activity, participants should be able to:

  • Identify appropriate candidates for antiviral therapy based on risk for influenza-related complications, in accordance with current guideline recommendations
  • Differentially diagnose influenza based on clinical presentation and accurate interpretation of appropriate diagnostic tests when necessary
  • Recommend individualized antiviral treatment plans for patients with influenza based on current data and unique agent characteristics
  • Advise on influenza prophylaxis based on evidence and in accordance with guideline recommendations

Agenda

  • Pharmacy and Flu: What’s New?
  • Pharmacy and Flu: Testing and Treatment
  • Pharmacy and Flu: Antiviral Therapy
  • Who Should Receive Antiviral Therapy?
  • Which Antiviral Should I Choose?
  • Faculty Discussion


Accreditation and Designation Statement 
Educational Review Systems is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. Participants of the session who complete the evaluation and provide accurate NABP e-Profile information will have their credit for 1.0 contact hours (0.10 CEU) submitted to CPE Monitor as early as 14 days after the event and no later than 60 days after the event. Please know that if accurate e-Profile information is not provided within 60 days of the event, credit cannot be claimed after that time. The participant is accountable for verifying the accurate posting of CE credit to their CPE Monitor account within 60 days. 

UAN # 0761-9999-21-294-H01-P; 0761-9999-21-294-H01-T
 
This is a knowledge-based activity.

Instructions for Participation 
To receive a CPE certificate of participation, you should:

  • Follow instructions to register or log in with your professional information and complete the preactivity assessment
  • View the online activity in its entirety
  • Complete and submit the online posttest and evaluation. You must answer 70% of the posttest questions correctly to earn credit. You will have unlimited opportunities to successfully complete the posttest

A certificate of participation will be available for download/printing immediately following your successful completion of the posttest and evaluation.

For questions regarding CPE credit, contact the Paradigm CME Department at (845) 398-5949 or cme@paradigmmc.com.

There is no fee required for participation in this activity.

Hardware/Software Requirements
This certified CME activity is designed using HTML5 web components. As you navigate the video using the supplied controls, the slides will sync to the speaker.

Supported Browsers (Desktop/Mobile)
Chrome 45+, Firefox 40+, Edge, Edge Chromium, Safari 8+, Opera 31+

PDF documents
This activity may contain PDF documents. Most current browsers support viewing of PDFs natively, but you may also download a free version of Adobe Acrobat Reader here: http://get.adobe.com/reader

Technical Support: If you have any technical problems or playback issues email us at contactus@paradigmmc.com.

Disclosures
In accordance with ACPE requirements on disclosure, faculty and contributors are asked to disclose any relationships with commercial interests associated with the area of medicine featured in the activity. These relationships are described below. Any potential conflicts of interest have been mitigated.

Jason E. Bowling, MD
Advisor: Eli Lilly and Company

James S. Lewis II, PharmD, FIDSA
Consulting Fees: Cidara Therapeutics, Inc; Merck & Co, Inc; Selux Diagnostics, Inc

Paradigm Medical Communications, LLC staff members have no financial relationship(s) to disclose.

Educational Review Systems, Inc. staff members have no financial relationship(s) to disclose. 

Independent peer reviewer has no financial relationship(s) to disclose.

Resolution of Conflict of Interest
Educational Review Systems, Inc and Paradigm Medical Communications, LLC have implemented a system to resolve conflicts of interest for each CPE activity to help ensure content is objective, fair and balanced, independent, and aligned with the public interest. Conflicts, if any, are resolved through one or more processes. All CPE content in this activity was independently reviewed to ensure that it is free of commercial bias, scientifically rigorous, aligned with the public interest, and compliant with all regulatory guidance and the ACPE guidelines.

Disclosure of Unlabeled Use
This educational activity may contain discussion of published and/or investigational uses of agents that are not approved by the FDA.


Disclaimer
This CPE activity represents the views and opinions of the individual faculty, and does not constitute the opinion or endorsement of, or promotion by, Educational Review Systems, Inc or Paradigm Medical Communications, LLC. Reasonable efforts have been taken to present educational subject matter in a balanced, unbiased fashion, and in compliance with regulatory requirements. However, each activity participant must always use his or her own personal and professional judgment when considering further application of this information, particularly as it may relate to patient diagnostic or treatment decisions including, without limitation, FDA-approved uses and any off-label uses.

If included, signed statements of informed consent granting permission for publication have been obtained for all photographs and videos in which an individual can be identified.

As accredited providers, Educational Review Systems, Inc and Paradigm Medical Communications, LLC must include a balanced view of therapeutic options. Use of generic names contributes to this impartiality. The use of trade names should not be viewed as an endorsement of specific products by Educational Review Systems, Inc or Paradigm Medical Communications, LLC. 

Terms of Use and Privacy Policy
Disclaimer
The materials provided for this activity are for informational purposes only, and should not be used for diagnosis or treatment of a health problem without consulting a licensed medical professional. This CPE activity represents the views and opinions of the individual faculty, and does not constitute the opinion or endorsement of, or promotion by, Educational Review Systems, Inc or Paradigm Medical Communications, LLC. References to any entity, product, service, or source of information on this website should not be considered an endorsement, either direct or implied, by Educational Review Systems, Inc or Paradigm Medical Communications, LLC. Educational Review Systems, Inc and Paradigm Medical Communications, LLC accept no liability for the content referenced in this activity.

Privacy policy
Educational Review Systems, Inc, Paradigm Medical Communications, LLC, or hosted contracted partner is committed to protecting the privacy of those who participate in the activities located at www.paradigmmc.com (herein referred to as “website”). The information below describes the security of the website for safeguarding personal information and the rationale for collection and use of personal information.

Security/safeguarding personal information
This website has physical and procedural safeguards in place to prevent unauthorized access to personal information used to access this website.

Collection and use of your personal information
The submission of certain personally identifiable information is necessary to award and track the credits participants may earn after completing the program. Required items include first name, last name, degree, and email address. These items are necessary. Participants are also required to complete an evaluation of the CPE activity. All evaluative information submitted is collected and retained, and used by Educational Review Systems, Inc and Paradigm Medical Communications, LLC to continuously improve the learning experience.

Educational Review Systems, Inc and Paradigm Medical Communications, LLC do not transfer, sell, or share personal information with outside parties. Educational Review Systems, Inc and Paradigm Medical Communications, LLC will not otherwise disclose personal information unless required to in a legal process. Educational Review Systems, Inc and Paradigm Medical Communications, LLC staff members review individual test results to the extent necessary to record and track participants’ credits.

Contact Us
If you have any questions or comments, please email us at contactus@paradigmmc.com. 

© 2021 Paradigm Medical Communications, LLC except where noted. Content may not be reproduced in whole or part without the express written permission of Paradigm Medical Communications, LLC.